Any lymphoma-related researches, either pathologically or clinically, are welcomed, particularly the underlying categories:
EBV-positive lymphoproliferative disorder, not fitting the diagnosis of lymphoma
Plasmablastic neoplasm, including but not restricted to plasmablastic lymphoma, plasmablastic myeloma, and other lymphoma with extensive plasmablastic differentiation
Atypical follicular helper T-cell hyperplasia or primary extranodal follicular helper T-cell lymphoma
Immune deficiency/dysregulation-related lymphoproliferative disorder or lymphoma, other than the following setting: transplantation, HIV, or presumed immune senescence (>60-year-old)
Indolent large B-cell lymphoma (spontaneous regression, excision and cure, or stable for more than 1 year without treatment)
Site specific B-cell lymphoma, including but not restricted to effusion-based lymphoma
multicentric Castleman disease or idiopathic plasmacytic lymphadenopathy
Any other interesting cases and research are all welcomed!
The panel (Taiwan Hematopathology Study Group) will select the most educational, interesting, or challenging cases/abstract for oral or poster presentation.
The submitting authors will be notified the decision by 2025/Dec/15.